AI matches radiologists in breast cancer screening study

NCT ID NCT07298252

Completed Diagnosis Sponsor: Carebot s.r.o. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an AI system called Carebot AI MMG to see if it can detect breast cancer from mammograms as accurately as human radiologists. Researchers looked at 222 past mammograms from four screening centers. The AI classified each exam as low, medium, or high risk, and its results were compared to readings from three experienced radiologists. The goal was to see if the AI could match or beat human performance in spotting cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm female breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER DETECTION BREAST CANCER FEMALE BREAST CANCER SCREENING BREAST NEOPLASMS

Contacts and locations

Locations

Dolnooravská nemocnica s poliklinikou MUDr. L. N. Jégého

Dolný Kubín, 026 14, Slovakia
Nemocnica s poliklinikou Považská Bystrica

Považská Bystrica, 017 01, Slovakia
Poliklinika MEDICON Budějovická

Prague, 14000, Czechia
Ľubovnianska nemocnica

Stará Ľubovňa, 064 01, Slovakia

More trials for these conditions

Other studies related to the condition(s) this trial covers.